| License: Creative Commons Attribution 4.0 PDF - Published Version Early view publication (528kB) | |
| PDF (530kB) | |
| License: Creative Commons Attribution 4.0 PDF - Published Version Final Version (530kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-439405
- DOI to cite this document:
- 10.5283/epub.43940
Abstract
Men treated for localized prostate cancer by radiotherapy have often a remaining life span of 10 yr or more. Therefore, the risk for secondary malignancies should be taken into account. Plans for ten patients were evaluated which had been performed on an Oncentra (R) treatment planning system for a treatment with an Elekta Synergy (TM) linac with Agility (TM) head. The investigated techniques ...
Owner only: item control page
Download Statistics